JUVE Patent

Steven Baldwin is a partner in Kirkland’s IP Litigation team in London with significant experience representing clients in patent, life sciences regulatory, trademark, copyright and trade secrets matters. His practice focuses primarily on complex cross-border telecommunications (SEP/FRAND) and life sciences patent disputes, as well as high-profile trade mark and trade secrets cases.

Steven is at the very forefront of the continuing development of global SEP/FRAND case law, advising his clients on business critical worldwide disputes as global coordinating counsel (including, e.g., the UK, US, China, Germany, the Netherlands and Italy). Key recent cases include Panasonic v Xiaomi, Lenovo v Ericsson, MediaTek v Huawei, InterDigital v Lenovo, Sisvel and Mitsubishi v Xiaomi/Oppo, IP Bridge v Huawei (intervening third party), Philips v TCL, and IPCom v Xiaomi.

Steven also regularly acts for the world’s largest pharmaceutical and biosimilar companies and has worked on numerous blockbuster medicines worth billions of dollars worldwide. Example blockbuster biologics and small molecule cases include Pfizer v Amgen, Boehringer v Teva, Regeneron v Kymab and Novartis v MedImmune. Steven also advises on the life sciences regulatory aspects of billion-dollar life sciences deals and has developed a particular interest in, and deep knowledge of, the law governing supplementary protection certificates (SPCs) – he is recognised as a thought leader and regular writer, speaker and commentator on the topic.

Steven’s case experience covers a broad range of technical fields including 3GPP, 3GPP2, DMR, TETRA and other wireless (standardised and non-standardised) mobile telecommunications technologies, organic chemistry, antibody biologics, biological product development and screening platforms, formulation science, next generation cancer treatments, and e-cigarette/vaping technologies.